home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences


  IBC's Formulation Strategies for Biopharmaceuticals  
  May 21, 2003

Gene Therapy

  IBC Life Sciences, Wyndham Philadelphia Hotel, Philadelphia, PA
September 22-24, 2003

Attend IBC’s Formulation Strategies for Biopharmaceuticals conference to obtain the solutions to your most pressing problems in developing formulations for protein & peptide therapeutics. Specifically, you will learn from leaders in industry and academia with new reports on protein stability, therapeutic specific formulations, practical issues involving analytical methods and process scale-up, as well as the potential for using protein engineering to improve stability profiles. Plus, for the first time, the Formulations meeting will be co-located with IBC’s Protein & Peptide Drug Delivery – expanding your networking opportunities and giving you the opportunity to attends sessions for this conference when you register for Formulations.
Organized by: IBC Life Sciences
Invited Speakers: Keynote Presentations:

John Carpenter, Ph.D., Co-Director, Center for Pharmaceutical Biotechnology, University of Colorado

Steven J. Shire, Ph.D., Senior Scientist/Group Leader, Pharmaceutical R&D, Genentech, Inc.

Deadline for Abstracts: -`
Registration: Phone (508) 616-5550 x1004 Fax (508) 616-5522+ Email reg@ibcusa.com Online www.LifeSciencesInfo.com/formulations
E-mail: reg@ibcusa.com
  Posted by:   James G. Prudhomme  
Host: host-65-124-112-226.ibcusa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.